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Multimodal Imaging of Brain Connectivity Using
the MIBCA Toolbox: Preliminary Application to
Alzheimer’s Disease
André Santos Ribeiro, Luís Miguel Lacerda, Nuno André da Silva, and Hugo Alexandre Ferreira
for the Alzheimer’s Disease Neuroimaging Initiative
Abstract—The Multimodal Imaging Brain Connectivity Anal-
ysis (MIBCA) toolbox is a fully automated all-in-one connectivity
analysis toolbox that offers both pre-processing, connectivity, and
graph theory analysis of multimodal images such as anatomical,
diffusion, and functional MRI, and PET. In this work, the MIBCA
functionalities were used to study Alzheimer’s Disease (AD) in
a multimodal MR/PET approach. Materials and Methods: Data
from 12 healthy controls, and 36 patients with EMCI, LMCI
and AD (12 patients for each group) were obtained from the
Alzheimer’s Disease Neuroimaging Initiative (ADNI) database
(adni.loni.usc.edu), including T1-weighted (T1-w), Diffusion
Tensor Imaging (DTI) data, and 18F-AV-45 (ﬂorbetapir) dynamic
PET data from 40-60 min post injection (4x5 min). Both MR and
PET data were automatically pre-processed for all subjects using
MIBCA. T1-w data was parcellated into cortical and subcortical
regions-of-interest (ROIs), and the corresponding thicknesses
and volumes were calculated. DTI data was used to compute
structural connectivity matrices based on ﬁbers connecting pairs
of ROIs. Lastly, dynamic PET images were summed, and the
relative Standard Uptake Values calculated for each ROI. Results:
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An overall higher uptake of 18F-AV-45, consistent with an in-
creased deposition of beta-amyloid, was observed for the AD
group. Additionally, patients showed signiﬁcant cortical atrophy
(thickness and volume) especially in the entorhinal cortex and
temporal areas, and a signiﬁcant increase in Mean Diffusivity
(MD) in the hippocampus, amygdala and temporal areas. Fur-
thermore, patients showed a reduction of ﬁber connectivity with
the progression of the disease, especially for intra-hemispherical
connections. Conclusion: This work shows the potential of the
MIBCA toolbox for the study of AD, as ﬁndings were shown to
be in agreement with the literature. Here, only structural changes
and beta-amyloid accumulation were considered. Yet, MIBCA
is further able to process fMRI and different radiotracers, thus
leading to integration of functional information, and supporting
the research for new multimodal biomarkers for AD and other
neurodegenerative diseases.
Index Terms—Alzheimer’s Disease, brain connectivity, graph
theory, image processing, magnetic resonance imaging, molecular
imaging, multimodal imaging, network theory, positron emission
tomography, toolbox.
I. INTRODUCTION
N EUROIMAGING techniques have long been used to un-fold the complexity of human brain anatomy and func-
tion. The neuroimaging technique of election to study brain con-
nectivity is Magnetic Resonance Imaging (MRI). MRI allows
measuring in vivo and non-invasively the human morphology,
structure and dynamics with high resolution and soft tissue con-
trast. Further, MRI has been extensively used in the context of
structural connectivity, where the measurement of the random
displacement of water molecules using diffusion MRI (dMRI)
allows the tracing of three-dimensional paths between different
brain regions via tractography [1], [2]. Functional connectivity,
on the other hand, typically uses functional MRI (fMRI), which
has helped undercover concepts about the basal level of activa-
tions in the brain (resting state networks) [3], [4].
However, MRI lacks molecular sensitivity and speciﬁcity,
when compared with Nuclear Medicine methods such as
Positron Emission Tomography (PET), which allows acquiring
quantitative molecular data. Furthermore, the broad spectrum
of radiotracers allows understanding diseases states of different
molecular pathways. On the other hand, PET presents low
spatial resolution and reduced anatomical information. The
combination of complementary information from multimodal
data is therefore highly desired. In fact, it has already been
This work is licensed under a Creative Commons Attribution 3.0 License. For more information, see http://creativecommons.org/licenses/by/3.0/
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shown that multimodal data brings new perspectives to the
knowledge of the brain and in particular it has been used to
ﬁnd biomarkers for neurological diseases, such as Alzheimer’s
Disease (AD) [5], [6].
Nonetheless, managing and processing such multimodal data
is not straightforward and it is time consuming. Moreover, pro-
cessing is often performed in a non-automatic manner that is
prone to human error. Current automatic multimodal methods
are still fairly limited, being majorly focused on one technique
[7]–[9].
In this paper we exploit the multimodal capability of the
fully automated all-in-one connectivity analysis toolbox -
Multimodal Imaging Brain Connectivity Analysis toolbox
(MIBCA). MIBCA offers pre-processing, connectivity and
graph theory analyses, and visualization of multimodal data
such as anatomical MRI (aMRI), dMRI, fMRI and PET. Here,
MIBCA was applied to AD as a preliminary proof-of-concept
study.
II. MATERIALS AND METHODS
In this section the ADNI database will be ﬁrstly described,
followed by the description of the subject groups, the neu-
roimaging sequences and the protocols used. Further, the
neuroimaging data processing and analysis performed by the
MIBCA toolbox will be introduced.
A. ADNI database
Data used in the preparation of this article were obtained
from the ADNI database (adni.loni.usc.edu). To date, over 1500
adults, aged 55 to 90, were recruited to participate in the re-
search, consisting of cognitively normal older individuals, pa-
tients with early or late Mild Cognitive Impairment (MCI), and
patients with AD. For up-to-date information, see www.adni-
info.org.
In this study, a total of 48 subjects of the ADNI-2 data-
base presenting concurrently volumetric T1-weighted (T1-w),
Diffusion Tensor Imaging (DTI) and PET data were studied.
Subjects belonged to 4 groups according to ADNI baseline
diagnosis: healthy controls (CTRL); and early MCI (EMCI),
late MCI (LMCI) and AD patients. Demographic data (age
and gender), Apolipoprotein E (ApoE) genotyping - absolute
frequency (2/3, 3/3, 3/4 and 4/4) - and Mini-Mental State
Examination (MMSE) are shown in Table I.
B. Neuroimaging data
MRI data including high-resolution T1-w and DTI data were
acquired using a 3T MRI scanner (Discovery MR750, Gen-
eral Electric, Milwaukee, U.S.A.) and an 8-channel receive-
only head coil. T1-w sequence (IR-SPGR) parameters include:
sagittal plane; ; ms;
; ; Voxel size
mm . DTI sequence (spin echo with echo planar readout):
axial plane; ; 41 non-colinear diffusion-sensitizing
gradient directions; , s/mm with 5 b0 acquisitions;
ms; ; Reconstruction matrix
; Voxel size mm .
In addition, a hybrid PET/Computed Tomography scanner
(Siemens, Erlangen, Germany) was used to acquire 18F-AV-45
TABLE I
DEMOGRAPHIC, GENETIC AND NEUROPSYCHOLOGICAL
CHARACTERIZATION OF SUBJECT GROUPS
F = Female; M = Male
Age at the time of diagnostic screening and imaging: mean
standard deviation and age range ( old). ApoE genotyping;
State Examination:
deviation scores and scores ranges; Kruskal-Wallis test: signiﬁcant difference
in MMSE ( ); individual Mann-Whitney tests:
signiﬁcant difference between CTRL group and LMCI ( ) and
AD ( ) patient groups;
signiﬁcant differences between EMCI and LMCI ( ), and AD
( ) patient groups;
signiﬁcant difference between LMCI and and AD ( ) patient
groups; No additional signiﬁcant differences were observed between subject
groups.
(ﬂorbetapir) dynamic PET data from 40-60 min post injection
( frames). PET data were acquired with the following
parameters: ; ; Voxel size
mm ; . Data were attenuation,
decay, random, and scatter corrected and reconstructed using
OSEM2D with 4 iterations and 16 subsets.
C. MIBCA Toolbox
The MIBCA toolbox is an application developed in
MATLAB. The toolbox combines and integrates multiple
freely available and referenced neuroimaging software pack-
ages and applications in order to optimize and automate data
processing within a multimodal imaging framework for brain
connectivity analysis [10], [11]. Combined neuroimaging tools
include Freesurfer [12], FSL [13], SPM [14], Diffusion Toolkit
[15] and the Brain Connectivity Toolbox [16]. Currently, the
MIBCA toolbox is able to process aMRI from high-resolution
T1-w images, dMRI from DTI, fMRI from blood oxygen level
dependent (BOLD) resting-state or task-related data (not used
in this study) and also PET data of distinct radiotracers [17].
The data processing (C.1) and analysis (C.2) performed on this
study is explained below and summarized in Table II.
1) Data Processing: Following a data folder hierarchy
“Study-Subject-Acquisition-Images” the toolbox automatically
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TABLE II
ANALYSED MODALITIES AND ASSOCIATED PRE-PROCESSING
AND EXTRACTED METRICS
identiﬁes and processes the different subjects in batch and
speciﬁcally for each modality. Due to the speciﬁcities of each
imaging modality, these will be discussed next.
aMRI is the ﬁrst modality to be processed by the toolbox.
This is the only modality that is required to be processed ﬁrst as
it deﬁnes the non-linear transform (subject-template) that is fur-
ther applied in all other modalities. Using pipelined Freesurfer,
the following pre-processing steps were applied: non-para-
metric non-uniform intensity normalization; skull stripping;
afﬁne and non-linear registration to the MNI305 atlas; segmen-
tation into gray and white-matter and cerebro-spinal ﬂuid; and
parcellation into cortical and subcortical regions-of-interest
(ROIs) according to the Desikan-Killiany-Tourville atlas. The
imaging metrics used in this study, including cortical thickness
(CThk), and gray matter volume (GMV) for cortical ROIs and
GMV for subcortical ROIs, are then collected and organized
from Freesurfer output using a speciﬁc toolbox script.
Diffusion images were ﬁrst corrected for eddy currents using
eddy_correct function (corrects for eddy current-induced distor-
tions and subject movements; available through FSL), and the
diffusion tensor was reconstructed from the raw images using
dti_recon function (available through Diffusion Toolkit). From
the reconstructed images, the Mean Diffusivity (MD) and Frac-
tional anisotropy (FA) maps were produced. Deterministic ﬁber
tracking was also performed with the diffusion toolkit using
the Fiber Assignment by Continuous Tracking (FACT) algo-
rithm to generate the streamlines from diffusion data. The T1-w
image was then afﬁne registered to the b0 diffusion image, and
the transformation applied to the atlas image registered to the
T1-w (obtained through the aMRI pipeline). The registered atlas
image is then used to extract the mean MD, FA and ﬁber count
for each ROI.
PET images were ﬁrst corrected for motion using SPM and
smoothed with an 8 mm Gaussian ﬁlter. The summed activity
was obtained from the dynamic PET data and afﬁne registered
to the T1-w image. The aligned ROIs were then mapped back
to the PET space. The summed image was then transformed to
relative Standard Uptake Values (rSUV) with the cerebellum as
the reference ROI. The registered atlas image was once more
used to extract the mean rSUV for each ROI.
2) Data Analysis: For each extracted metric the average and
standard deviation value for each of the studied groups (CTRL,
EMCI, LMCI, and AD) was automatically obtained.
Additionally, from ﬁber tracking data, structural connectivity
matrices were automatically computed by determining the
number of ﬁbers connecting each ROI pair (FiberConn).
Then, using Graph theory analysis, the node degree (Deg) and
clustering coefﬁcient (ClusC) metrics were calculated from the
matrices. Deg represents the number of regions to which a par-
ticular region is connected to, and thus translates howmuch that
region is integrated or communicates with different networks.
ClusC of a region represents the fraction of that region’s neigh-
bours (i.e. to which the region is connected to) that are neigh-
bours of each other, and therefore translates how segregated is a
particular region and associated network regarding others. This
segregated network may correspond, for instance, to a particular
brain function.
D. Statistical Analysis
Subject group demographic data (age and gender), ApoE
genotype and MMSE scores were analysed regarding mean,
standard deviation, and range values, and regarding absolute
frequencies when appropriate. Subject groups (controls and
patients) where compared regarding age and MMSE using
Kruskal-Wallis and Mann-Whitney U tests, and Gender and
ApoE genotype using the Chi-square test. Non-parametric tests
were used due to the low number of subjects per group. The
statistical analysis was done using PASW Statistics 21 software
and a signiﬁcance of was used.
Statistical differences between each 2 groups were computed
directly by the toolbox for each imaging and connectivity metric
and also for FiberConn. Here, the Mann-Whitney U test with
was also used whilst controlling for age and gender.
Summarizing, the analysed metrics for this study were: CThk
and GMV from aMRI; MD, FA, Deg, ClusC and FiberConn
from dMRI and rSUV from 18F-AV-45 data.
III. RESULTS AND DISCUSSION
In this section group characterization will be ﬁrstly discussed
regarding values and statistical tests performed. Then connec-
tivity results and imaging metrics will be presented and dis-
cussed for each group comparison (e.g. CTRL vs EMCI). Fi-
nally, an overall discussion will be done regarding ﬁndings for
all groups studied.
A. Group characterization
It can be seen from Table I that MMSE scores decrease
monotonically from the CTRL to the EMCI, LMCI and AD
patient groups, as expected. In fact a highly signiﬁcant overall
difference in MMSE was found using Kruskal-Wallis test
( ). Individual comparisons between group pairs
using the Mann-Whitney test hold also signiﬁcant differences
( ) with the exception of CTRL vs EMCI with no
observable signiﬁcant difference.
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Fig. 1. Connectograms for CTRL vs (EMCI, LMCI and AD), for EMCI vs (LMCI, and AD), and for LMCI vs AD. The outermost rings represent Freesurfer
T1-weighted segmented cortical (right hemisphere–light gray; left hemisphere–darker gray) and subcortical (black) brain regions. The inner rings from the outer-
most to the innermost respectively represent gray matter volume, cortical thickness, mean diffusivity, fractional anisotropy, node degree and clustering coefﬁcient
of the structural DTI matrix, and PET relative standard uptake value. Red and blue squares respectively represent signiﬁcant lower or higher values of the corre-
sponding ring metric for the second group in comparison to the ﬁrst. In the center is a representation of structural DTI connectivity (ﬁbers connecting different
brain regions). Red and blue lines respectively represent signiﬁcantly decreasing or increasing number of ﬁbers between groups. Here more intense colors represent
higher signiﬁcances and therefore larger group differences. The Mann-Whitney U test was applied with signiﬁcance . (see supplementary material for a
higher magniﬁcation of this image).
This exception is to be expected if one considers that often
small differences in the clinical assessment and the limitations
of neuropsychological testing can result in one subject being
classiﬁed in one or another group, especially when clinical ﬁnd-
ings are subtle and diagnosis is unsure as is the case of pa-
tients with EMCI [12]. Additionally, statistical tests showed
that the 4 groups are age- (Kruskall-Wallis and Mann-Whitney
tests), gender and ApoE genotype matched (Chi-square tests),
meaning that differences between groups found in the following
analysis should arise from pathology only and/or other co-vari-
ables herein not considered. This is crucial since age, for ex-
ample, has been proven to confound the effect of AD in speciﬁc
regions along the cortical surface [18], [19].The multimodal
imaging connectivity group comparison analysis is presented in
Fig. 1 and Table III, and will be discussed further below.
608 IEEE TRANSACTIONS ON NUCLEAR SCIENCE, VOL. 62, NO. 3, JUNE 2015
B. Connectivity Analysis CTRL vs EMCI
Even though, no signiﬁcant differences were observed be-
tween groups regarding demographics, ApoE genotyping and
MMSE scores, differences in several temporal lobe regions
were observed regarding different imaging and connectivity
metrics. Particularly, the left hemispherical (Lh) inferior tem-
poral gyrus (ITG) showed a decrease in GMV and the superior
temporal gyrus (STG) showed a decrease in GMV and also an
increase in MD. The right hemispherical (Rh) ITG and the tem-
poral pole (TP) both showed an increase in MD and a decrease
in FA, and the Rh STG showed only an increase in MD. All
the identiﬁed temporal regions are known to be affected in AD,
namely regarding the loss of gray-matter and tissue architecture
resulting in a decrease in GMV and an increase in MD [20].
A decreasing structural connectivity was also observed for
the Rh-STG and the Hippocampus (Hip). In fact, for the Hip,
changes were observed in white-matter (decrease in the number
of tracts) whilst no GMV changes were observed which agrees
with a recent work, where it was observed that white-matter
changes precede hippocampal atrophy in EMCI patients [21].
Additionally, an increase in Deg and a decrease in ClusC
were observed for the Lh medial orbito-frontal cortex (MeOFC)
and Rh superior parietal lobule (SPL) and Nucleus Accumbens
(Acc). The Rh-SPL also showed an increased rSUV, consistent
with the uptake of the beta-amyloid speciﬁc 18F-AV-45 tracer.
These regions are also known to be affected in AD [20], [22],
[23]. In particular, structural changes in the orbitofrontal cortex
have been observed in patients with MCI and AD 4 years be-
fore any cognitive symptoms [24]. Interestingly, in this work
changes were identiﬁed using the connectivity metrics but not
the imaging metrics, suggesting that the former may be more
sensitive to particular tissue structural changes than imaging
metrics. More recent studies have validated this ﬁnding and
further evaluated the use of different features in the differen-
tiation between MCI and AD groups, and controls, suggesting
improvements in the accuracy of the classiﬁcation when using
network measures [25], [26]. The fact that Deg increases and
ClusC decreases may suggest that these regions establish addi-
tional connections with regions other than the ones from the tra-
ditional network as a means to compensate other brain regions
losses. Given the small studied groups further studies would be
necessary to conﬁrm this hypothesis.
C. Connectivity Analysis CTRL vs LMCI
It can be observed from the connectograms in Fig. 1 that
differences between groups were more extensive. In particular,
changes in additional temporal lobe regions associated with AD
were observed, including the: ITG, STG and middle temporal
gyrus (MTG), Hip, Amygdala (Amg), and entorhinal cortex
(ERC). Also, other regions known also to be changed in AD
were observed, including: the fusiform gyrus (FG) bilaterally,
the supramarginal gyrus (SMG), the inferior parietal lobule
(IPL), the precuneus (PCn) and the frontal pole (FP) [27].
Again, the connectivity metrics identiﬁed changes regarding
the Deg and ClusC of the MeOFC. Intriguingly, the Rh-MeOFC
showed an opposite behaviour to what was described before for
the Lh-MeOFC: a decrease in Deg and an increase in ClusC.
This fact could be interpreted as a region losing some of the
connections to the outside of its nearest- neighbour network,
resulting in an increased segregation. Nonetheless, an overall
decrease/increase in structural connectivity was observed in the
Lh/Rh, respectively. It is also worth considering that although
AD causes cell atrophy locally and it might have a speciﬁc pat-
tern of progression which affects the white matter tracts in dif-
ferent ways [28], some studies, have actually reported different
results in connectivity for the same regions [29].
Additionally, an overall rSUV increase was observed in the
patient group, with the exemption of most basal ganglia struc-
tures. Interestingly, the putamen showed also a higher 18-AV-45
uptake which is consistent among patient groups EMCI, LMCI
and AD. Uptake changes in the putamen have also been ob-
served in other studies [30], [31].
D. Connectivity Analysis CTRL vs AD
In this comparison, even more pronounced changes compar-
atively to both CRTL-EMCI and CRTL-LMCI were observed.
In fact, several of the regions identiﬁed as different between
CTRL vs LMCI, were here different as well, and also different
in additional metrics. Such are the cases of the Lh-ITG, MTG,
SMG, and of the Rh-TP, Hip, ERC, IPL, parahippocampalgyrus
(PHG), and several parcels of the middle frontal gyrus (MFG)
and the insula (Ins). Most of the changes were observed as GMV
and CThk decreases and MD increases [20]. In fact, MD has
been identiﬁed as a more sensitive measure than FA to identify
differences between controls and different groups, such as MCI
and AD [32], which might explain why there were changes in
MD in more regions than when compared to FA.
As before, the Lh-MeOFC showed an increase in Deg and
a decrease in ClusC. Also, a decrease in ClusC was observed
for Lh-Hip and Amg, and an increase in ClusC was observed
for Rh-TP. Interestingly, the Lh-Hip also showed a decrease in
rSUVwhich suggests an extensive tissue change. Otherwise, the
overall increase in rSUV translates the extensive dissemination
of beta-amyloid deposition [30].
Lastly, a bilateral decrease in connections with the Hip and
with other temporal structures such as the Amg, PHG, STG,
MTG, ITG, and TP and also with FP were observed suggesting
an extensive compromise of the brain’s structural connectivity.
This ﬁnding is corroborated by previous studies that have im-
plicated changes in cortical regions such as the PHG regarding
white matter, which helps explaining and predicting the progres-
sion of the disease [33].
E. Connectivity Analysis EMCI vs LMCI
Differences between the EMCI and LMCI groups were ob-
served mainly in the Lh-FP, which could translate the deteri-
oration of cognitive functions as assessed by the MMSE. Ad-
ditional changes were observed in the MTG, ERC, PHG, Amg
and also in the cingulate gyrus and in the basal ganglia: palidum
(Pd), putamen (Pt) and thalamus (Tha). These latter changes
could also be associated with cognitive decline [34].
Further, the Rh-Tha showed a decrease in ClusC and in rSUV
and the Lh-Tha showed a decrease in the number of ﬁbers con-
necting to the TP. Additional decreases in the number of ﬁber
connections included: Lh-FP and Lh-Ins; Lh-STG and Lh-ITG;
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TABLE III
REGIONAL SIGNIFICANT CHANGES IN MULTIMODAL IMAGING METRICS AND CONNECTIVITY PARAMETERS IN SUBJECT GROUPS COMPARISONS
and Rh-STG and Rh-PCn. These regions have been recently as-
sociated with differences in cortical thicknesses observed be-
tween these two groups of patients [35].
F. Connectivity Analysis EMCI vs AD
In this test, the observed differences are similar to the ones
found in the comparison between CTRL and AD groups. The
main differences include the extension of changes of the ERC
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and PHG regarding decrease in GMV and CThk and increase in
MD, suggesting that these structures are particularly affected in
the progression from EMCI to AD. As before, the Lh-MeOFC
appears to have a role in disease progression, as it is known to
have strong connections to the hippocampus and the ERC and
participate in decision-making and reward cognitive processes
[36], [37].
Interestingly, a bilateral Deg decrease in the precentral gyrus
(PCG) and the Acc was observed. The latter also showed in-
creased rSUV. This suggests that PCG changes may be associ-
ated with known gait variability in MCI and AD patients [38]
and increased changes in Acc [37].
Finally, decreases in rSUV were also observed for Hip bilat-
erally and for Rh-Tha, and also several inter-hemispheric con-
nections were observed to be reduced.
G. Connectivity Analysis LMCI vs AD
It can be observed that the main differences between groups
are related to a higher predominance of changes in temporal re-
gions such as the Hip and the ITG, and also of the SMG and
the Acc. Interestingly, the GMV observed to be decreased bilat-
erally for the pars orbitalis may be related to known deﬁcits in
semantic ﬂuency [39], [40].
Once more, the Hip showed decreased rSUV with bilateral
decreasing number of ﬁber connections, which may translate an
increased damage to this structure.
H. Overall Connectivity changes in AD
Although this study is preliminary and based in a small co-
hort, the obtained results are in agreement with the main known
ﬁndings regarding AD, such as: a decrease of both GMV and
CThk [41], and an increase of the MD in temporal, frontal and
parietal regions [42], [43]; an increasingly compromised whole-
brain structural connectivity [44], [45]; and also a generalized
increase in the accumulation of beta-amyloid plaque [46], [47].
Moreover, our preliminary results showed a low sensitivity of
the 18F-AV-45 radiotracer for differentiation between CTRL-
EMCI and LMCI-AD; and a reduction of ﬁber connectivity with
the progression of the disease, especially for intra-hemispherical
connections.
This study is also in agreement with a very recent study [48]
in which a related dataset and connectivity analysis were also
used. The authors of this study concluded that the beta-amyloid
burden, as measured by 18F-AV-45, was related to changes in
structural connectivity metrics.
In addition, it was shown that the MIBCA toolbox is a
framework suitable for automated processing and comprehen-
sive analysis of multimodal data, with the potential to facilitate
the discovery of new aspects of physiopathology and novel
biomarkers of disease.
IV. CONCLUSION
The potential of the MIBCA toolbox for the automatic
pre-processing, analysis, visualization and integration, of neu-
roimaging data applied to the study of AD was presented. The
ﬁndings obtained using the toolbox were in agreement with the
literature for AD. In addition, signiﬁcant differences in both
imaging and connectivity metrics found in group comparisons,
such as in CTRL vs EMCI, warrant further investigations
which may lead to the identiﬁcation of biomarkers for early
AD diagnosis.
In resume, the MIBCA toolbox can integrate multimodal in-
formation without increasing the workload of the researcher.
The researcher is only required to manually place the imaging
data in the speciﬁed hierarchy, deﬁning the different contrasts
and regression variables, and then select, in the toolbox’s in-
terface, the data types and the analyses to be performed. The
following pre-processing and analyses is done automatically in
batch. The researcher is ﬁnally able to explore the data through
an integrated visualization tool. These featuresmake the toolbox
especially useful for novel and improved studies where mul-
timodal information is presented, such as in hybrid MR/PET
scanners.
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